Docosahexaenoyl glycerol

Docosahexaenoyl glycerol is an analog of endocannabinoid, which stimulates the glucose uptake and exhibits anti-inflammatory efficacy[1][2].

Product Specifications

CAS Number

[140670-40-2]

UNSPSC

12352211

Hazard Statement

H302-H315-H319-H335

Target

Cannabinoid Receptor

Type

Reference compound

Related Pathways

GPCR/G Protein; Neuronal Signaling

Applications

COVID-19-immunoregulation

Field of Research

Inflammation/Immunology

Assay Protocol

https://www.medchemexpress.com/docosahexaenoyl-glycerol.html

Purity

99.0

Solubility

DMSO : 100 mg/mL (ultrasonic)

Smiles

OCC(O)COC(CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CC)=O

Molecular Formula

C25H38O4

Molecular Weight

402.57

Precautions

P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501

References & Citations

[1]Dotsey E, et al., Transient Cannabinoid Receptor 2 Blockade during Immunization Heightens Intensity and Breadth of Antigen-specific Antibody Responses in Young and Aged mice. Sci Rep. 2017 Feb 17;7:42584.|[2]Price CA, et al., Plasma fatty acid ethanolamides are associated with postprandial triglycerides, ApoCIII, and ApoE in humans consuming a high-fructose corn syrup-sweetened beverage. Am J Physiol Endocrinol Metab. 2018 Aug 1;315 (2) :E141-E149. doi: 10.1152/ajpendo.00406.2017IF: 5.1 Q1 . Epub 2018 Apr 10.